Cargando…
Cellular hierarchy framework based on single-cell/multi-patient sample sequencing reveals metabolic biomarker PYGL as a therapeutic target for HNSCC
BACKGROUND: A growing body of research has revealed the connection of metabolism reprogramming and tumor progression, yet how metabolism reprogramming affects inter-patient heterogeneity and prognosis in head and neck squamous cell carcinoma (HNSCC) still requires further explorations. METHODS: A ce...
Autores principales: | Guan, Jiezhong, Xu, Xi, Qiu, Guo, He, Chong, Lu, Xiaoyue, Wang, Kang, Liu, Xinyu, Li, Yuanyuan, Ling, Zihang, Tang, Xuan, Liang, Yujie, Tao, Xiaoan, Cheng, Bin, Yang, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329320/ https://www.ncbi.nlm.nih.gov/pubmed/37420300 http://dx.doi.org/10.1186/s13046-023-02734-w |
Ejemplares similares
-
High PYGL Expression Predicts Poor Prognosis in Human Gliomas
por: Zhao, Chang-yi, et al.
Publicado: (2021) -
PYGL-mediated glucose metabolism reprogramming promotes EMT phenotype and metastasis of pancreatic cancer
por: Ji, Qian, et al.
Publicado: (2023) -
Novel PYGL mutations in Chinese children leading to glycogen storage disease type VI: two case reports
por: Luo, Xiaomei, et al.
Publicado: (2020) -
Hepatic glycogenolysis is determined by maternal high-calorie diet via methylation of Pygl and it is modified by oteocalcin administration in mice
por: Kawakubo-Yasukochi, Tomoyo, et al.
Publicado: (2021) -
Glycogen storage disease type VI with a novel PYGL mutation: Two case reports and literature review
por: Zhan, Qian, et al.
Publicado: (2021)